Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

[Evaluation of the action of glucomannan on metabolic parameters and on the sensation of satiation in overweight and obese patients].

Cairella M, Marchini G.

Clin Ter. 1995 Apr;146(4):269-74. Italian.

PMID:
7796558
[PubMed - indexed for MEDLINE]
2.

Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial.

Salas-Salvadó J, Farrés X, Luque X, Narejos S, Borrell M, Basora J, Anguera A, Torres F, Bulló M, Balanza R; Fiber in Obesity-Study Group.

Br J Nutr. 2008 Jun;99(6):1380-7. Epub 2007 Nov 22.

PMID:
18031592
[PubMed - indexed for MEDLINE]
3.

[Chronic use of glucomannan in the dietary treatment of severe obesity].

Vita PM, Restelli A, Caspani P, Klinger R.

Minerva Med. 1992 Mar;83(3):135-9. Italian.

PMID:
1313163
[PubMed - indexed for MEDLINE]
4.

Effects of intramural administration of Botulinum Toxin A on gastric emptying and eating capacity in obese patients.

Foschi D, Lazzaroni M, Sangaletti O, Corsi F, Trabucchi E, Bianchi Porro G.

Dig Liver Dis. 2008 Aug;40(8):667-72. doi: 10.1016/j.dld.2008.02.040.

PMID:
18420471
[PubMed - indexed for MEDLINE]
5.

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.

Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J.

Diabetes Obes Metab. 2000 Apr;2(2):105-12.

PMID:
11220522
[PubMed - indexed for MEDLINE]
6.

[Effects of oligofructose containing diet in obese persons].

Antal M, Regöly-Mérei A, Biró L, Arató G, Schmidt J, Nagy K, Greiner E, Lásztity N, Szabó C, Péter S, Martos E.

Orv Hetil. 2008 Oct 19;149(42):1989-95. doi: 10.1556/OH.2008.28387. Hungarian.

PMID:
18842551
[PubMed - indexed for MEDLINE]
7.

The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial.

Hanefeld M, Sachse G.

Diabetes Obes Metab. 2002 Nov;4(6):415-23.

PMID:
12406041
[PubMed - indexed for MEDLINE]
8.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
[PubMed - indexed for MEDLINE]
9.

Effect of hydrolyzed guar fiber on fasting and postprandial satiety and satiety hormones: a double-blind, placebo-controlled trial during controlled weight loss.

Heini AF, Lara-Castro C, Schneider H, Kirk KA, Considine RV, Weinsier RL.

Int J Obes Relat Metab Disord. 1998 Sep;22(9):906-9.

PMID:
9756250
[PubMed - indexed for MEDLINE]
10.

The effect of guar gum addition to a semisolid meal on appetite related to blood glucose, in dieting men.

Kovacs EM, Westerterp-Plantenga MS, Saris WH, Melanson KJ, Goossens I, Geurten P, Brouns F.

Eur J Clin Nutr. 2002 Aug;56(8):771-8.

PMID:
12122554
[PubMed - indexed for MEDLINE]
Free Article
11.

A diet rich in long chain omega-3 fatty acids modulates satiety in overweight and obese volunteers during weight loss.

Parra D, Ramel A, Bandarra N, Kiely M, Martínez JA, Thorsdottir I.

Appetite. 2008 Nov;51(3):676-80. doi: 10.1016/j.appet.2008.06.003. Epub 2008 Jun 14.

PMID:
18602429
[PubMed - indexed for MEDLINE]
12.

Changes in the sensation of hunger and well-being before and after meals in overweight/obese women following two types of hypoenergetic diet.

Rodríguez-Rodríguez E, Aparicio A, Bermejo LM, López-Sobaler AM, Ortega RM.

Public Health Nutr. 2009 Jan;12(1):44-50. doi: 10.1017/S1368980008001912. Epub 2008 Mar 7.

PMID:
18325135
[PubMed - indexed for MEDLINE]
13.

Effect of mazindol on body weight and insulin sensitivity in severely obese patients after a very-low-calorie diet therapy.

Nishikawa T, Iizuka T, Omura M, Kuramoto N, Miki T, Ito H, Chiba S.

Endocr J. 1996 Dec;43(6):671-7.

PMID:
9075607
[PubMed - indexed for MEDLINE]
Free Article
14.

Effect of glucomannan on obese patients: a clinical study.

Walsh DE, Yaghoubian V, Behforooz A.

Int J Obes. 1984;8(4):289-93.

PMID:
6096282
[PubMed - indexed for MEDLINE]
15.

Effect of conjugated linoleic acid supplementation after weight loss on appetite and food intake in overweight subjects.

Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS.

Eur J Clin Nutr. 2003 Oct;57(10):1268-74.

PMID:
14506488
[PubMed - indexed for MEDLINE]
16.

Beneficial effects of metformin in normoglycemic morbidly obese adolescents.

Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S.

Metabolism. 2001 Dec;50(12):1457-61.

PMID:
11735093
[PubMed - indexed for MEDLINE]
17.

The effects of dexfenfluramine on weight loss and cardiovascular risk factors in female patients with upper and lower body obesity.

Ditschuneit HH, Flechtner-Mors M, Adler G.

J Cardiovasc Risk. 1996 Aug;3(4):397-403.

PMID:
8946272
[PubMed - indexed for MEDLINE]
18.

Effects of a carbohydrate-restricted diet with and without supplemental soluble fiber on plasma low-density lipoprotein cholesterol and other clinical markers of cardiovascular risk.

Wood RJ, Fernandez ML, Sharman MJ, Silvestre R, Greene CM, Zern TL, Shrestha S, Judelson DA, Gomez AL, Kraemer WJ, Volek JS.

Metabolism. 2007 Jan;56(1):58-67.

PMID:
17161227
[PubMed - indexed for MEDLINE]
19.

Glucomannan and obesity: a critical review.

Keithley J, Swanson B.

Altern Ther Health Med. 2005 Nov-Dec;11(6):30-4. Review.

PMID:
16320857
[PubMed - indexed for MEDLINE]
20.

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.

Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP; Sibutramine/Diabetes Clinical Study Group.

Diabetes Obes Metab. 2000 Jun;2(3):175-87.

PMID:
11220553
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk